Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |